Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.67
Delayed Data
As of May 26
 +0.10 / +0.23%
Today’s Change
37.20
Today|||52-Week Range
45.58
+10.80%
Year-to-Date

Today’s Trading

Previous close42.57
Today’s open42.84
Day’s range42.58 - 42.91
Volume4,963,611
Average volume (3 months)3,186,808
Market cap$104.9B
Dividend yield4.66%
Data as of 4:02pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+12.66%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+2.85%
P/E ratio62.6
Price/Sales2.52
Price/Book74.77

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.26-0.39%
CELGCelgene+0.04+0.03%
BMYBristol-Myers Squibb-0.42-0.77%
LLYEli Lilly and Co-0.29-0.37%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.69
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts